Last Update 03 Oct 2025

Welcome to RPPEO's Drug Availability Database, a one stop site for information on drug availability for Ontario Paramedicine.

This database covers drugs that are used under the Advance Life Support Patient Care Standards (v5.2 10Jul2023) and ACP Palliative Care Treat & Refer (v2.1, 20Mar2021), including those drugs under research protocols or expected in the near future. The purpose of this database is to provide information on drug availability so that Paramedic Services, Base Hospitals, and the Ministry of Health can proactively manage drug shortages, thus ensuring the residents of Ontario have access to appropriate and equitable healthcare.

The Drug Availability Database is maintained by the Regional Paramedic Program for Eastern Ontario (RPPEO) on a publicly accessible site, with data manually entered on a weekly basis, primarily from Health Canada's Drug Product Database, Drug Shortages Canada, and the Government of Canada's Recalls and Safety Alerts. Secondary sources include ad hoc updates on drug availability, expiry date extensions, recall notices, etc. from paramedic services, pharmaceutical suppliers, and manufacturers. We welcome drug availability information from users of the Drug Availability Database; please email information to RPPEO-Quality@toh.ca.

Using the Drug Availability Database

Drugs are listed in alphabetical order of active ingredient, then manufacturer and trade name. Included in the Drug (Active Ingredient) column is the ATC code, and the Equipment Standards (v3.7 01Feb2023) requirements.
The drug Status is current to the last modified date/time shown directly under the title of this page, according to the legend below. The last two columns, Notes and JIRA, are only completed if applicable; the former containing relevant information, while the later contains restricted-access organization-specific case management links.
Certain drugs are optional, used for research, expected soon, or not included in either the equipment standards or the ALS PCS, these are indicated in magenta text.
If the drug preparation used within your Paramedic Service is not included in the Drug Availability Database, please email the particulars to RPPEO-Quality@toh.ca and we will add these.
Drug presentations carried by paramedic services within the RPPEO region are indicated in the RPPEO column
For technical issues please email RPPEOBHITS@rppeo.ca

Drug Status Legend

Status	Meaning
Available	No Drug Shortage report and no Paramedic Services reporting supply issues
Available	No Drug Shortage reported and no Paramedic Services reporting supply issues, but there is information to consider
Supplier Issue	No Drug Shortage report, but Paramedic Services reporting supply issues
Anticipated Shortage	Anticipated Drug Shortage reported
Shortage	Drug Shortage reported
Discontinued (date)	Drug has been discontinued but supply is potentially still in use until date indicated. Will be removed from list after stated date.
(T3)	May be combined with Anticipated Shortage, Shortage, or Discontinuation. Represents the potential for highest impact on Canada's healthcare

Drug Availability Database

Drug (Active Ingredient)	Manufacturer	Trade Name	DIN	Presentation	Status	Notes	RPPEO	JIRA
Acetaminophen N02BE01 All units Min: 1920 mg Std: 960 - 1000 mg/dose Checked 13-Mar-2024	Apotex	Acetaminophen Tablets USP	02362244	500 mg tablet	Available		Y
	Apotex	Acetaminophen Tablets USP	02362422	325 mg tablet	Available
	Apotex	APO-Acetaminophen	00544981	325 mg tablet	Shortage	Estimated end 11-Nov-2025
	Apotex	Apo-Acetaminophen caplets extra strength	02229977	500 mg tablet	Shortage	Estimated end 31-Oct-2025	Y
	Apotex	Apo-Acetaminophen extra strength	00545007	500 mg tablet	Available		Y
	Apotex / CareRx	Apo-Acetaminophen caplets	02229873	325 mg tablet	Shortage	Estimated end 31-Oct-2025	Y
	Cellchem Pharmaceuticals	Acetaminophen Tablets Extra Strength	02252813	500 mg tablet	Available
	Cellchem Pharmaceuticals	Acetaminophen Tablets Regular Strength	02252805	325 mg tablet	Available
	JAMP Pharma	JAMP Acetaminophen 325	01938088	325 mg tablet	Available	https://recalls-rappels.canada.ca/en/alert-recall/jamp-acetaminophen-tablet-overweight-underweight-tablets?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23 Recall for lot numbers: EG22AMP013, EG22AMP014, EG22AMP015
	JAMP Pharma	JAMP Acetaminophen 500	01939122	500 mg tablet	Available	https://recalls-rappels.canada.ca/en/alert-recall/jamp-acetaminophen-tablet-overweight-underweight-tablets?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23 Recall for lot numbers: EG22AMQ034, EG22AMQ035, EG22AMQ036, EG22AMQ042
	JAMP Pharma	JAMP Acetaminophen Blazon 500	02355299	500 mg tablet	Shortage	Dormant until 31-Dec-2023
	Laboratoire Riva	Acetaminophene Blason Shield	02362201	500 mg tablet	Shortage	Dormant, TBD
	Laboratoire Riva	Acetaminophene caplet	02362228	500 mg tablet	Available		Y
	Laboratoire Riva	Acetaminophene comprime tablet	02022222	500 mg tablet	Shortage	Dormant, TBD
	Laboratoire Riva	Acetaminophene comprime tablet	02022214	325 mg tablet	Available
	Laboratories Trianon	Acetaminophen Tab USP	00789798	500 mg tablet	Available
	Laboratories Trianon	Acetaminophen Tab USP	00789801	325 mg tablet	Available
	McNeil Consumer Healthcare	Tylenol extra strength	00559407	500 mg tablet	Available
	McNeil Consumer Healthcare	Tylenol rapid release	00863270	500 mg tablet	Available
	McNeil Consumer Healthcare	Tylenol regular strength	00559393	325 mg tablet	Available
	Teva	Novo-Gesic	00389218	325 mg tablet	Available
	Teva	Novo-Gesic Forte	00482323	500 mg tablet	Available
	Vita Health Products	Acetaminophen Tablets	00605751	325 mg tablet	Available
	Vita Health Products	Extra strength acetaminophen	02285797	500 mg tablet	Available
	Vita Health Products	Extra strength acetaminophen tablets	00605778	500 mg tablet	Available
	Zee Medical	Painaid Free Acetaminophen Tablets	02144514	500 mg tablet	Available
Adenosine C01EB10 ACP units Min: 36 mg Std: 6 and/or 12 mg preparations Checked 13-Mar-2024	Fresenius Kabi	Adenosine Injection	02267659	3 mg/ml in 2 ml vial	Available		Y
	Fresenius Kabi	Adenosine Injection	02457474	6 mg in 2 ml prefilled syringe	Available		Y
	Fresenius Kabi	Adenosine Injection	02457482	12 mg in 4 ml prefilled syringe	Shortage	Estimated end 15-May-2024 Adenosine Injection 3 mg/mL Prefilled syringe 2 mL will be available for substitution.	Y
Amiodarone C01BD01 ACP units if not carrying lidocaine injection Min: 600 mg Std: n/a Checked 13-Mar-2024	Fresenius Kabi	Amiodarone hydrochloride injection	02245248	50 mg/ml in 3 ml vial	Anticipated Shortage	Estimated end 24-Aug-2024	Y
	JAMP Pharma	Amiodarone hydrochloride injection	02423227	50 mg/ml in 3 ml vial	Shortage	Estimated end 12-Mar-2024
	Sandoz	Amiodarone hydrochloride injection	02242325	50 mg/ml in 3 ml vial	Available		Y
	Sandoz	Amiodarone hydrochloride injection	02242325	50 mg/ml x 9 ml vial	Available
Antibiotic eye drops S01HA03 Chem-Ex Auxiliary Checked 13-Mar-2024	Bausch & Lomb	Minims Tetracaine Hydrochloride	02148528	0.5% in 5 ml	Available		Y
Antibiotic ointment D06AX30 Special Event Auxiliary Checked 13-Mar-2024	Johnson & Johnson	Polysporin Antibiotic Cream	02230844	15 g or 30 g tube	Available
	Johnson & Johnson	Polysporin Antibiotic Ointment	02237227	15 g or 30 g tube	Available		Y
	Johnson & Johnson	Polysporin Complete	02240568	15 g or 30 g tube	Available
	Johnson & Johnson	Polysporin Triple Antibiotic Ointment	02237226	15 g or 30 g tube	Available
ASA (Acetylsalicylic acid) B01AC06 N02BA01 All units Min: 6 tablets Std: 80 or 81 mg tablets Checked 13-Mar-2024	Altamed Pharma	ASA	02497115	80 mg chewable tablet	Available
	Bayer	Aspirin 81 mg quick chews	02289970	81 mg chewable tablet	Available
	Biomed Pharma	BIO-ASA	02515687	80 mg chewable tablet	Shortage	Dormant, TBD	Y
	CareRx	ASA chew	unknown	80 mg			Y
	JAMP Pharma	JAMP-ASA Chew	02269139	80 mg chewable tablet	Available		Y
	Laboratoire Riva	RIVASA Croquable - Tab	02202352	80 mg chewable tablet	Available
	Mantra Pharma	M-ASA Croquable	02429950	80 mg chewable tablet	Available
	Odan Laboratories	ASATAB Chewable Tablets	02280167	80 mg chewable tablet	Available		Y
	Pendopharm	Entrophen Chewable	02243974	81 mg chewable tablet	Available
	Pharmascience	ASA daily low dose	02394790	81 mg chewable tablet	Available
	Pharmascience	ASAPHEN	02009013	80 mg chewable tablet	Available	Drug Shortage Report for ASAPHEN	Y
	Pro Doc	PRO-AAS (Croquable)	02311518	80 mg chewable tablet	Available	Drug Shortage Report for PRO-AAS - 80 (CROQUABLE)
Atropine A03BA01 ACP units Min: 2 mg Std: n/a Checked 13-Mar-2024	Hikma / Teligent	Atropine Injection BP	02432188	0.4 mg/ml in 1 ml ampoule	Available		Y
	Hikma / Teligent	Atropine Injection BP	02432196	0.6 mg/ml in 1 ml ampoule	Available		Y
	Labortoire Aguettant	Atropine Sulfate Injection	02426277	1 mg in 5 ml prefilled syringe	Available		Y
	Pfizer	Atropine Sulfate Injection USP Abboject LifeShield	00328154	1 mg in 10 ml prefilled syringe	Discontinued (18-Aug-2025)	Drug Shortage Report for ATROPINE SULFATE INJECTION USP Estimated discontinuation 18-Aug-2025 Recall notice: 20 Sep 2023 ATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass particulate.	Y
	Sandoz	Atropine Sulfate Injection USP	00392693	0.6 mg/ml in 1 ml ampoule	Available		Y
	Sandoz	Atropine Sulfate Injection USP	00392782	0.6 mg/ml in 1 ml ampoule	Available
Buprenorphine/Naloxone N07BC51 Optional	Indivior	Suboxone	02295709	8 mg/2 mg SL tablet	Available
	Indivior	Suboxone	02502348	8 mg/2 mg soluble film	Available
	Pharmascience	PMS-Buprenorphine-Naloxone	02424878	8 mg/2 mg SL tablet	Available
	Teva	Teva-Buprenorphine/Naloxone	02453916	8 mg/2 mg SL tablet	Shortage	Estimated end 31-Jan-2026
Calcium Gluconate B05BB01 ACP units Min: 4 g Std: 10% (1g/10 ml)	Fresenius Kabi	Calcium Gluconate USP 10%	02141019	100 mg/ml in 10 ml vial	Available		Y
Dexamethasone H02AB02 All units Min: 16 mg Std: n/a	Omega Laboratories	Dexamethasone Omega Unidose	02387743	10 mg/ml x 1 ml vial	Available		Y
	Omega Laboratories	Dexamethasone-Omega	02204266	4 mg/ml x 5 ml vial	Shortage	Estimated end 15-Nov-2024
	Omega Laboratories	Dexamethasone-Omega	02204274	10 mg/ml x 1 ml vial	Anticipated Shortage
	Sandoz	Dexamethasone Sodium Phosphate Inj USP	00664227	4 mg/ml x 5 ml vial	Available		Y
	Sandoz	Dexamethasone Sodium Phosphate Inj USP	00874582	10 mg/ml x 1 ml	Available		Y
Dextrose B05BA03 ACP/PCP (AIV) units Min: 4 Std: 10% (10 g/100 ml) OR 50% (25 g/50 ml) Alternative names: 10% = D10 or 100 mg/ml 50% = D50 or 500 mg/ml	B Braun	10% Dextrose Injection USP	01924427	(100 mg/ml) 10% in 500 ml IV bag	Available		Y
	B Braun	10% Dextrose Injection USP	01924427	(100 mg/ml) 10% in 250 ml IV bag	Available		Y
	Baxter	10% Dextrose Injection, USP	00060364	(100 mg/ml) 10% in 500 ml IV bag	Available
	Omega Laboratories	Dextrose Injection	02517132	(500 mg/ml) 50% in 50 ml vial	Shortage	Estimated end, 31-Oct-2025 Some product available at CPDN. We have released a batch, but the product is still subject to allocation.
	Pfizer	Dextrose Injection USP	02468514	(500 mg/ml) 50% in 50 ml vial	Shortage	Estimated end, TBD Affected lot number: LH2756 & LY3589 EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination. - Canada.ca
		ANSYR syringe		(500 mg/ml) 50% in 50 ml prefilled syringe	Available	Lifeshield syringe discontinued, ANSYR syringe remains available
		LifeShield syringe		(500 mg/ml) 50% in 50 ml prefilled syringe	Discontinued (18-Aug-2025)	ANSYR syringe remains available
Diazepam N05BA01 Chem-Ex Auxiliary Not in equipment standards	Sandoz	Diazepam injection USP	00399728	5 mg/ml in 2 ml ampoules	Available
DimenhyDRINATE R06AA11 All units Min: 100 Std: n/a	Church & Dwight	Gravol IM	00013579	50 mg/ml in ampoule	Shortage	Estimated end unknown	Y
	Hikma	DimenhyDRINATE Injection USP	02428954	50 mg/ml x 1 ml ampoule	Available		Y
	Sandoz	DimenhyDRINATE Injection USP	00392537	50 mg/ml x 1 ml ampoule	Available		Y
DiphenhydrAMINE (injection) R06AA02 All units Min: 100 mg Std: n/a	Fresenius Kabi	DiphenhydrAMINE Hydrochloride Injection	02369567	50 mg/ml in 1 ml vial	Available		Y
	Omega Laboratories	Diphenist	02219336	50 mg/ml in 1 ml vial	Avoided Shortage	Estimated end 30-Sept-2025 They are currently collaborating with Health Canada's Drug Shortages Unit to mitigate any market impact.	Y
	Sandoz	DiphenhydrAMINE Hydrochloride Injection USP	00596612	50 mg/ml in 1 ml	Available		Y
DiphenhydrAMINE (oral) R06AA02 Special Event Auxiliary	JAMP Pharma	JAMP DiphenhydrAMINE	02257548	25 mg tablet	Available
	JAMP Pharma	JAMP DiphenhydrAMINE	02257556	50 mg tablet	Available
	Laboratoire Lalco	Dormiphen extra-forte comprime	02237789	50 mg tablet	Available
	McNeil Consumer Healthcare	Extra strength Benadryl allergy	02470144	50 mg tablet	Available
	McNeil / Johnson & Johnson	Benadryl allergy	02017849	25 mg tablet	Available		Y
	Paladin Labs	Unisom	01946986	50 mg tablet	Available
	Tanta Pharmaceuticals	Allergy formula extra strength	02532484	50 mg tablet	Available
	Teva	Allernix	02097583	25 mg tablet	Discontinued	Discontinued 2019-07-31 due to business reasons
	Teva	Allernix extra strength	02097575	50 mg tablet	Discontinued	Discontinued 2019-07-31 due to business reasons
	Vita Health Products	Allergy formula	02229492	25 mg tablet	Available
	Vita Health Products	Allergy formula extra strength	02490943	50 mg tablet	Available
Dopamine C01CA04 ACP units Min: 2 bags Std: 200 mg/250 ml OR ~~200 mg/5 ml~~	Baxter	Dopamine HCL 0.8mg/ml Dextrose 5% Inj USP	00761850	0.8 mg/ml in 250 ml solution	Available		Y	CMP-32879
EPINEPHrine 1:1,000 (1 mg/ml) C01CA24 All units Min: 10 mg Std: n/a	Hikma	EPINEPHrine Injection USP	02435810	1 mg/ml in 1 ml ampoule	Available		Y
	Pfizer	EPINEPHrine Injection USP	00721891	1 mg/ml in 1 ml ampoule	Available	Drug Shortage Report for EPINEPHRINE INJECTION USP	Y
	Searchlight Pharma	Adrenalin	00155357	1 mg/ml in 1 ml ampoule	Available
	Searchlight Pharma	Adrenalin	00155357	1 mg/ml in 30 ml vial	Available		Y
EPINEPHrine 1:10,000 (0.1 mg/ml) C01CA24 ACP units Min: 10 mg Std: n/a	Laboratoire Aguettant	EPINEPHrine Injection	02521148	1 mg in 10 ml prefilled syringe	Shortage	Estimated end Sep-09-2024
	Pfizer	EPINEPHrine Injection USP, LifeShield	00710814	1 mg in 10 ml prefilled syringe	Discontinued (18-Aug-2025)	Drug Shortage Report for EPINEPHRINE INJECTION USP Affected lot number: LR4585, LN2814, LN2813 & LX1239 EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination. - Canada.ca	Y	CMP-35519
Fentanyl N01AH01 N02AB03 Optional Min: 400 mcg Std: n/a	Fresenius Kabi	Fentanyl Citrate Injection, USP	02501554	50 mcg/ml in 2 ml vial	Available
	Hikma	Fentanyl Citrate Injection USP	02385406	50 mcg/ml in 2 ml vial	Shortage	Estimated end, TBD	Y
	JAMP Pharma	Fentanyl Citrate Injection	02506963	50 mcg/ml in 2 ml vial	Available
	Sandoz	Fentanyl Citrate Injection USP	02240434	50 mcg/ml in 2 ml vial	Available		Y
	Sandoz	Fentanyl Citrate Injection USP	02384124	50 mcg/ml in 2 ml vial	Available		Y
	Sterimax	Fentanyl Injection BP	02496143	50 mcg/ml in 2 ml ampoule	Shortage	Estimated end 18-Aug-2025
Glucagon H04AA01 All units Min: 2 mg Std: n/a	Amphastar Pharmaceuticals	Glucagon Injection	US FDA 0548-5850-00	1 mg as powder for reconstitution	Unknown	US product that may be imported until 31 Dec 2024		CMP-34086
	Amphastar Pharmaceuticals	BAQSIMI	02492415	3 mg powder in nasal dosing device	Available	Change in packaging site		CMP-34086
	Eli Lilly	Glucagon	02243297	1 mg as powder for reconstitution	Discontinued (T3)	Last supplies have been delivered.	Y	CMP-34086
	Novo Nordisk	Glucagen	02333619	1 mg as powder for reconstitution	Discontinued	Remaining supply 29-Feb-2024		CMP-34086
	Novo Nordisk	Glucagen Hypokit	02333627	1 mg as powder for reconstitution	Discontinued	Remaining supply 29-Feb-2024 See Report ID: 198052. The product will be discontinued with a stock depletion date of February 29, 2024.	Y	CMP-34086
Glucose (oral) All units Min: 2 Std: 15 g/dose as paste, tables, or other formulation	Not considered a drug by Health Canada
Glycopyrrolate A03AB02 Palliative Not listed in Equipment Standards	JAMP Pharma	Glycopyrrolate Injection USP	02513749	0.2 mg/ml in 2 ml vial	Available
	Omega Laboratories	Glycopyrrolate injection	02382857	0.2 mg/ml in 1 ml vial	Shortage	Estimated end 31-Oct-2025
	Omega Laboratories	Glycopyrrolate injection	02382857	0.2 mg/ml in 2 ml vial	Available		Y
	Sandoz	Glycopyrrolate Injection USP	02039508	0.2 mg/ml in 1 ml vial	Available
	Sandoz	Glycopyrrolate Injection USP	02039508	0.2 mg/ml in 2 ml vial	Available		Y
	Sterimax	Glycopyrrolate Injection USP	02473879	0.2 mg/ml in 1 ml vial	Shortage	Estimated end 31-Oct-2025
	Sterimax	Glycopyrrolate Injection USP	02473895	0.2 mg/ml in 2 ml vial	Available		Y
Haloperidol N05AD01 Palliative Not listed in Equipment Standards	Fresenius Kabi	Haloperidol injection USP	02406411	5 mg/ml in 1 ml vial	Available
	Omega Laboratories	Haloperidol injection	02366010	5 mg/ml in 1 ml vial	Available		Y
	Sandoz	Haloperidol injection USP	00808652	5 mg/ml in 1 ml ampoule	Available		Y
HYDROmorphone N05AD03 Palliative Not listed in Equipment Standards	Fresenius Kabi	HYDROmorphone Hydrochloride Injection, USP	02491680	10 mg/ml in 1 ml vial	Available	Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION, USP Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our HYDROmorphone Hydrochloride Injection, USP 10 mg/mL SD Vial 1 mL effective June 7, 2024 until June 28, 2024.
	Fresenius Kabi	HYDROmorphone Hydrochloride Injection, USP	02491699	2 mg/ml in 1 ml vial	Anticipated Shortage	Estimated end 19-Jul-2024
	JAMP Pharma	HYDROmorphone Hydrochloride Injection USP	02529645	2 mg/ml in 1 ml vial	Available
	Sandoz	HYDROmorphone HP 10	02145928	10 mg/ml in 1 ml vial	Available		Y
	Sandoz	HYDROmorphone Hydrochloride Injection USP	02145901	2 mg/ml in 1 ml vial	Available		Y
	Sterimax	HYDROmorphone Hydrochloride Injection HP 10	02460610	10 mg/ml in 1 ml vial	Available		Y
	Sterimax	HYDROmorphone Hydrochloride Injection USP	02460602	2 mg/ml in 1 ml vial	Available
Hydroxocobalamin V03AB33 Chem Ex Sodium Thiosulfate 25% is appropriate substitute Not in equipment standards	Serb SA	Cyanokit	02375370	5 g powder for infusion in glass vial	Available (T3)		Y
Ibuprofen M01AE01 All units Min: 800 mg Std: 400 mg/dose	Apotex	Apo-Ibuprofen	00441643	200 mg tablet	Available	Drug Shortage Report for APO-IBUPROFEN 1000 BTL available	Y
	Apotex	Apo-Ibuprofen	00506052	400 mg tablet	Available	Drug Shortage Report for APO-IBUPROFEN 100 BTL shortage, 1000 BTL available	Y
	Apotex	Apo-Ibuprofen	02439689	200 mg tablet	Available
	GlaxoSmithKline	Advil tablets	01933558	200 mg tablet	Available
	GlaxoSmithKline / CareRx	Advil extra strength caplets (CareRx)	02244577	400 mg tablet	Available		Y
	JAMP Pharma	Ibuprofen	02257912	200 mg tablet	Available
	JAMP Pharma	Ibuprofen	02317338	400 mg tablet	Available
	McNeil Consumer Healthcare	Motrin	02186934	200 mg tablet	Available
	McNeil Consumer Healthcare	Motrin	02242658	400 mg tablet	Available
	Pharmascience	Extra Strength Ibuprofen	02314770	400 mg tablet	Available
	Pharmascience	Ibuprofen Tablets	02314754	200 mg tablet	Available
	Vita Health Products	Ibuprofen Tablets	02272849	200 mg tablet	Available
	Vita Health Products	Ibuprofen Tablets	02368072	200 mg tablet	Available
Ketamine N01AX03 ACP units Min: 1000 mg Std: n/a	Sandoz	Ketamine Hydrochloride USP	02246796	50 mg/ml in 10 ml vial	Available	Stock available at wholesalers.	Y	CMP-36120
	Sandoz	Ketamine Hydrochloride USP	02246796	50 mg/ml in 2 ml vial	Available		Y
	Searchlight Pharma	Ketalar	00224405	50 mg/ml in 10 ml vial	Available
	Searchlight Pharma	Ketalar	00224391	10 mg/ml in 20 ml vial	Available
Ketorolac M01AB15 All units Min: 2 vials/amps Std: 10 - 15 mg/dose	Atnahs Pharma	TORADOL IM	02162644	10 mg/ml in 1 ml ampoule	Available
	Fresenius Kabi	Ketorolac Tromethamine Injection, USP	02244947	30 mg/ml in 1 ml vial	Available		Y
	Juno Pharmaceuticals	Ketorolac Tromethamine Injection, USP	02443376	30 mg/ml in 1 ml vial	Available		Y
	Pfizer	Ketorolac Tromethamine Injection, USP	02390582	30 mg/ml in 1 ml vial	Shortage	Estimated end TBD
	Sandoz	Ketorolac Tromethamine Injection, USP	02239944	30 mg/ml in 1 ml vial	Discontinued	Remaining supply date 30-Sept-2025
Lidocaine injection C01BB01 ACP units if not carrying amiodarone Min: 600 mg Std: n/a	Aspen Pharmacare	Xylocard	00001937	20 mg/ml in 5 ml ampoule	Anticipated Shortage	Estimated end 30-Sep-2024	Y
	Laboratoire Aguettant	Lidocaine Hydrochloride injection	02522268	100 mg in 5 ml prefilled syringe	Available
	Pfizer	Lidocaine Hydrochloride injection USP: Ansyr	00436208	100 mg in 5 ml prefilled syringe	Shortage	Estimated end TBD On allocation	Y	CMP-35516
	Pfizer	Lidocaine Hydrochloride injection USP: LifeShield	00436208	100 mg in 5 ml prefilled syringe	Shortage	Estimated end, TBD	Y	CMP-35516
Lidocaine spray N01BB02 ACP units Min: 2 Std: 10 mg/spray	Aspen Pharmacare	Xylocaine Spray	02003767	10 mg/metered dose spray	Available
Lidocaine spray N01BB02 ACP units Min: 2 Std: 10 mg/spray	Odan Laboratories	Lidoan endotracheal non-aerosol spray	02231147	10 mg/metered dose spray	Available		Y
Methoxyflurane 99.9% N02BG09 Research Project Not in equipment standards	Endo Ventures	Penthrox	2474727	3 ml bottle and inhaler	Available
Midazolam N05CD08 ACP units Min: 20 mg Std: n/a	Fresenius Kabi	Midazolam injection	02242905	5 mg/ml x 2 ml vial	Available
	Pfizer	Midazolam injection USP	02382350	5 mg/ml x 2 ml vial	Available
	Pfizer	Midazolam injection USP	02382385	5 mg/ml x 2 ml vial	Available
	Sandoz	Midazolam injection	02240286	5 mg/ml x 2 ml vial	Available		Y
Morphine N02AA01 ACP units Min: 40 mg Std: n/a	Fresenius Kabi	Morphine Sulfate injection, USP	02482746	10 mg/ml in 1 ml vial	Available	Drug Shortage Report for MORPHINE SULFATE INJECTION, USP Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Morphine Sulfate Injection, USP 10 mg / mL SD Vial 1 mL effective April 25, 2025, until July 18, 2025.
	JAMP Pharma	Morphine Sulfate injection	02500728	10 mg/ml in 1 ml ampoule	Available
	JAMP Pharma	Morphine Sulfate injection	02500736	15 mg/ml in 1 ml ampoule	Available
	Sandoz	Morphine Sulfate injection USP	02382997	10 mg/ml in 1 ml ampoule	Available		Y
	Sandoz	Morphine Sulfate injection USP	00392561	15 mg/ml in 1 ml ampoule	Available
	Sandoz	Morphine Sulfate injection BP	00392588	10 mg/ml in 1 ml ampoule	Available		Y
	Sterimax	Morphine Sulfate injection BP	02474980	15 mg/ml in 1 ml ampoule	Available
Naloxone V03AB15 All units Min: 12 mg Std: n/a	Hikma	Naloxone hydrochloride injection USP	02382482	0.4 mg/ml in 1 ml ampoule	Shortage	Estimated end 01-Mar-2024	Y
	Hikma	Naloxone injectable	02458578	0.4 mg/ml in 1 ml ampoule	Available
	Omega Laboratories	Injectable naloxone hydrochloride	02455935	0.4 mg/ml in 1 ml vial	Available
	Sandoz	Naloxone HCL Injection	02148706	0.4 mg/ml in 1 ml ampoule	Available
	Sandoz	Naloxone HCL Injection	02148714	1 mg/ml in 2 ml vial	Available		Y
	Sandoz	S.O.S. Naloxone hydrochloride injection	02453258	0.4 mg/ml in 1 ml ampoule	Available
Nitroglycerin C01DA02 All units Min: 2 canisters or bottles Std: 0.4 mg/dose, aerosol OR 0.3 or 0.4 mg/dose tablets	BGP Pharma	Nitrostat	00037613	0.3 mg SL tablet	Available			CMP-32011
	Juno Pharmaceuticals	Glyceryl trinitrate sublingual spray	UK PL 18190/0013	0.4 mg/metered dose spray	Unknown	UK product that may be imported until 31 Jan 2024		CMP-32011
	Mylan Pharmaceuticals	Mylan-Nitro Sublingual Spray	02243588	0.4 mg/metered dose spray	Discontinued	Discontinued 2024-05-01-The last lots and expiry dates are 0F904/30-Jun-2023 and 0G910/31-Jul-2023 - Reported in shortage ID 181369 Expiry date extension		CMP-32011
	Sandoz	Rho-Nitro Pumpspray	02238998	0.4 mg/metered dose spray	Shortage	Estimated end TBD Limited inventory available.	Y	CMP-32011
	Sanofi-Aventis	Nitrolingual Pumpspray	02231441	0.4 mg/metered dose spray	Shortage (T3)	Estimated end 30-Jun-2024		CMP-32011
Ondansetron injection A04AA01 Palliative	Auro Pharma	Auro-ondansetron injection	02491524	2 mg/ml in 2 ml vial	Available	Drug Shortage Report for AURO-ONDANSETRON INJECTION
	Auro Pharma	Auro-ondansetron injection	02491532	2 mg/ml in 2 ml vial	Available
	Auro Pharma	Ondansetron Injection BP	02461420	2 mg/ml in 2 ml ampoule	Available
	Marcan Pharmaceuticals	Ondansetron Injection USP	02503905	2 mg/ml in 2 ml vial	Available		Y
	Sandoz	Ondansetron Hydrochloride Dihydrate Injection	02274418	2 mg/ml in 2 ml ampoule	Available		Y
	Sandoz	Ondansetron Injection USP	02279428	2 mg/ml in 2 ml vial	Available
	Sterimax	Ondansetron Injection USP	02464578	2 mg/ml in 2 ml vial	Available	Drug Shortage Report for ONDANSETRON INJECTION USP Inventory remains available at McKesson	Y
Ondansetron oral A04AA01 All units Min: 8 mg Std: n/a	Accel Pharma	Accel-Ondansetron ODT	02535319	4 mg orally disintegrating tablet	Shortage	Estimated end 15-Jun-2024 Recall: https://recalls-rappels.canada.ca/en/alert-recall/accel-ondansetron-odt-4-8-mg-data-integrity-concerns-product-s-bioequivalence-data
	Athena Pharamaceutiques	Athena-ondansetron ODT	02444674	4 mg orally disintegrating tablet	Available
	Auro Pharma	Auro-ondansetron ODT	02511282	4 mg orally disintegrating tablet	Available	Drug Shortage Report for AURO-ONDANSETRON ODT	Y
	JAMP Pharma	Ondansetron ODT	02519232	4 mg orally disintegrating tablet	Available		Y
	Marcan Pharmaceuticals	Mar-Ondansetron ODT	02514966	4 mg orally disintegrating tablet	Available		Y
	Mint Pharmaceuticals	Mint-Ondansetron ODT	02487330	4 mg orally disintegrating tablet	Available		Y
	Pharmascience	PMS-Ondansetron ODT	02519445	4 mg orally disintegrating tablet	Available		Y
	Sandoz	Ondansetron ODT	02481723	4 mg orally disintegrating tablet	Available		Y
	Sandoz	Zofran ODT	02239372	4 mg orally disintegrating tablet	Available
	Takeda	Ondissolve	02389983	4 mg oral soluble film	Shortage	Estimated end 31-Oct-2025 Drug Shortage Report for ONDISSOLVE ODF
Oxytocin H01BB02 All units Min: 20 units (2 doses) Std: 10 units/ml	Fresenius Kabi	Oxytocin Injection USP	02139561	10 units/ml in 1 ml vial	Available		Y	CMP-33205
	Pfizer	Oxytocin Injection USP	00497398	10 units/ml in 1 ml ampoule	Shortage	Estimated end 30-Sept-2024		CMP-33205
Pralidoxime V03AB13 Chem Ex Not in equipment standards	Not marketed in Canada
Salbutamol inhalation solution R03AC02 All units Min: 25 mg Std: n/a	Pharmascience	PMS-Salbutamol	02208229	2.5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 10-Mar-2025	Y
	Pharmascience	PMS-Salbutamol	02208237	5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 03-Mar-2025	Y
	Teva	Teva-Salbutamol Sterinebs	01926934	2.5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 10-Feb-2025	Y
	Teva	Teva-Salbutamol Sterinebs	02173360	5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 31-Mar-2025	Y
Salbutamol MDI R03AC02 All units Min: 2 canisters Std: 100 mcg/puff, aerosol	Apotex	Apo-Salbutamol HFA	02245669	100 mcg/metered dose MDI	Available (T3)	Drug Shortage Report for APO-SALBUTAMOL HFA	Y
	GlaxoSmithKline	Ventolin HFA	02241497	100 mcg/metered dose MDI	Available	Drug Shortage Report for VENTOLIN HFA Increase in demand coupled with delay in shipment of the drug. Inventory on allocation to support demand.	Y
	Sanis Health	Salbutamol HFA	02419858	100 mcg/metered dose MDI	Available	Drug Shortage Report for SALBUTAMOL HFA
	Teva	Teva-Salbutamol HFA	02326450	100 mcg/metered dose MDI	Available (T3)	Drug Shortage Report for TEVA-SALBUTAMOL HFA Product in on allocation for duration of shortage.	Y
Sodium Bicarbonate B05XA02 ACP units Min: 2 Std: 50 mEq/50 ml (50 ml of 84 mg/ml)	Fresenius Kabi	Sodium Bicarbonate Injection, USP	02486636	50 mEq in 50 ml vial	Shortage	Estimated end 09-Dec-2025 Due to a delay in production, we will be encountering a supply interruption effective October 1, 2025, until December 9, 2025. Sterimax is an alternate supplier of this product and will be able to provide coverage during this time.	Y
	JAMP Pharma	Sodium Bicarbonate Injection USP	02516225	50 mEq in 50 ml vial	Available	Allocation
	Omega Laboratories	Sodium Bicarbonate Injection USP	02467585	50 mEq in 50 ml vial	Available		Y
	Pfizer	Sodium Bicarbonate Injection USP, ABBOJECT Syringe	00261998	50 mEq in 50 ml prefilled syringe	Available
	Pfizer	Sodium Bicarbonate Injection USP, fliptop Vial		50 mEq in 50 ml vial	Shortage	Estimated end TBD On allocation	Y
	Pfizer	Sodium Bicarbonate Injection USP, LifeShield Syringe		50 mEq in 50 ml prefilled syringe	Discontinued (18-Aug-2025)	50mL vial format remains available	Y
Sodium Chloride 0.9% (diluent) B05XA03 V07AB Not in equipment standards	BD	PosiFlush	None	10 ml prefilled syringe	unknown		Y
	Hikma / Teligent	0.9% Sodium Chloride Injection USP	02304341	10 ml ampoule	Available		Y
	Omega Laboratories	0.9% Sodium Chloride Injection USP	02150204	10 ml vial	Available
	Pfizer	Bacteriostatic Sodium Chloride Injection USP	00037818	10 ml vial	Available
	Pfizer	Sodium Chloride Injection USP	00037796	10 ml vial	Anticipated Shortage	Estimated end TBD Inventory on allocation	Y
Sodium Chloride 0.9% (IV fluid) B05XA03 ACP/PCP (AIV) units Min: 2 litres Std: ES 190 (any combination for 2 litre volume)	B. Braun Medical	0.9% Sodium Chloride Injection USP	01924303	100 ml IV bag	Available
				250 ml IV bag	Available
				500 ml IV bag	Available
				1000 ml IV bag	Available		Y
	Baxter	0.9% Sodium Chloride Injection, USP	00060208	50 ml IV bag	Shortage	Estimated end Aug-12-2024	Y
				100 ml IV bag	Available	Recall notice https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&
				250 ml IV bag	Shortage	Estimated end Aug-30-2024	Y
				500 ml IV bag	Available	Recall notice https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&	Y
				1,000 ml IV bag	Available	Recall notice https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&	Y
	Fresenius Kabi	0.9% Sodium Chloride Injection	02395150	50 ml IV bag	Available
				100 ml IV bag	Available
				250 ml IV bag	Available
				500 ml IV bag	Shortage	Estimated end 19-Nov-2024 This product is on backorder.
				1000 ml IV bag	Available
	ICU Medical	Sodium Chloride Injection USP	00037842	50 ml IV bag	Anticipated Shortage	Estimated end unknown
				100 ml IV bag	Available
				250 ml IV bag	Available	Drug Shortage Report for SODIUM CHLORIDE INJECTION USP
				500 ml IV bag	Available	Drug Shortage Report for SODIUM CHLORIDE INJECTION USP	Y
Sodium Thiosulfate 25% V03AB06 Chem Ex Hydroxocobalamin is appropriate substitute Not in equipment standards	Hope Pharmaceuticals	Sodium Thiosulfate injection USP	02428393	250 mg/ml in 50 ml vial	Available
	Pfizer	Sodium Thiosulfate injection USP	02137186	250 mg/ml in 10 ml vial	Available
	Seaford Pharmaceuticals	Seacalpyx	02386666	250 mg/ml in 100 ml vial	Available
Tranexamic Acid B02AA02 Expected drug	Auro Pharma	Tranexamic Acid injection	02466015	100 mg/ml in 10 ml ampoule	Available
	JAMP Pharma	Tranexamic Acid injection	02497328	100 mg/ml in 10 ml vial	Available
	Omega Laboratories	Tranexamic Acid injection	02392763	100 mg/ml in 10 ml vial	Available
	Pfizer	Cyklokapron	02064413	100 mg/ml in 10 ml ampoule	Shortage	Estimated end 09-Feb-2026
	Sandoz	Tranexamic Acid injection BP	02246365	100 mg/ml in 10 ml vial	Available
	Searchlight Pharma	ERFA-Tranexamic	02457431	100 mg/ml in 10 ml vial	Shortage	Estimated end, TBD
Water for Injection (flush/diluent) V07AB Not in equipment standards	Hikma	Sterile Water for Injection USP	02299186	10 ml ampoule	Available
	Hikma	Sterile Water for Injection USP	02299186	10 ml vial	Available
	Omega Laboratories	Sterile Water for Injection USP	00402257	10 ml vial	Available
	Pfizer	Sterile Water for Injection USP	02142546	10 ml vial	Anticipated Shortage
Xylometazoline 0.1% R01AA07 Optional Min: 2 bottles Std: n/a	CRLS	Decongestant Nasal Spray	02452812	0.1% spray, nasal spray	Available
	CRLS	Decongestant Nasal Spray with moisturizers	02452863	0.1% spray, nasal spray	Available
	GlaxoSmithKline	Otrivin Medicated Cold & Allergy Relief	00653330	0.1% spray, nasal spray	Available		Y
	GlaxoSmithKline	Otrivin Medicated Cold & Allergy Relief with moisturizers	02208903	0.1% spray, nasal spray	Available		Y
	GlaxoSmithKline	Otrivin Medicated Complete Nasal Care	02331403	0.1% spray, nasal spray	Available

The Drug Availability Database was developed and compiled by James Bowen, with the RPPEO, 2023.

The data for the Drug Availability Database is publicly available, however the collection and layout represents intellectual labour of RPPEO staff, where this is used please credit the RPPEO and James Bowen

Page tree

Drug Availability Database

Last Update 03 Oct 2025

Welcome to RPPEO's Drug Availability Database, a one stop site for information on drug availability for Ontario Paramedicine.

Using the Drug Availability Database

Drug Status Legend

Drug Availability Database

Acetaminophen

Adenosine

Amiodarone

Antibiotic eye drops

Antibiotic ointment

ASA (Acetylsalicylic acid)

Atropine

Buprenorphine/Naloxone

Calcium Gluconate

Dexamethasone

Dextrose

Diazepam

DimenhyDRINATE

DiphenhydrAMINE(injection)

DiphenhydrAMINE(oral)

Dopamine

EPINEPHrine 1:1,000 (1 mg/ml)

EPINEPHrine 1:10,000 (0.1 mg/ml)

Fentanyl

Glucagon

Glucose (oral)

Glycopyrrolate

Haloperidol

HYDROmorphone

Hydroxocobalamin

Ibuprofen

Ketamine

Ketorolac

Lidocaine injection

Lidocaine spray

Methoxyflurane 99.9%

Midazolam

Morphine

Naloxone

Nitroglycerin

Ondansetron injection

Ondansetron oral

Oxytocin

Pralidoxime

Salbutamol inhalation solution

Salbutamol MDI

Sodium Bicarbonate

Sodium Chloride 0.9% (diluent)

Sodium Chloride 0.9% (IV fluid)

Sodium Thiosulfate 25%

Tranexamic Acid

Water for Injection (flush/diluent)

Xylometazoline 0.1%

DiphenhydrAMINE
(injection)

DiphenhydrAMINE
(oral)